Orthofix Medical vs Varex Imaging
Varex Imaging reported revenue of $845 million in fiscal 2025, about the same as Orthofix Medical's $822 million in fiscal 2025. Orthofix Medical's revenue grew 2.9% in its latest year, and Varex Imaging's grew 4.1%. Orthofix Medical had an operating margin of -9.9%, against -3.3% at Varex Imaging. Free cash flow was −$1 million at Orthofix Medical and $19 million at Varex Imaging. Their fiscal years end in different months (December 31 and October 3), so the periods don't line up exactly.
Side by side
| Orthofix Medical | Varex Imaging | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Oct 3, 2025 |
| Revenue | $822M | $845M |
| Revenue growth | 2.9% | 4.1% |
| Revenue growth a year, last 5 years | 15.1% | 2.7% |
| Gross margin | 68.8% | 34.4% |
| Operating margin | −9.9% | −3.3% |
| Net margin | −11.2% | −8.3% |
| Free cash flow | −$1M | $19M |
| Free cash flow margin | −0.2% | 2.2% |
| Return on capital | −11.3% | −2.9% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 3.9% | 1.5% |
| Last close | $6.34 | $18.14 |
| P/E at the last close | — | 34.2× |
| Insider trades, last 12 months | bought $4.1 million, sold $6.6 million | sold $2.6 million |
| Piotroski F-score | 5 of 9 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Orthofix MedicalVarex Imaging
Operating margin
Percent of revenue
Orthofix MedicalVarex Imaging
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Orthofix MedicalVarex Imaging
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Orthofix Medical and Varex Imaging pages.